Chuan Lin – Chairman, TTY Biopharm, Taiwan
Chuan Lin, chairman of TTY Biopharm, one of Taiwan’s leading domestic biomedical players, highlights his ambition to lead the local success story onto the global stage. Chuan goes on to…
The Development Fund of the Executive Yuan is in its 30th year since establishment in 1973. In its early years, the Fund invested in petrochemical and semiconductor industries that were vital to national development plans. In recent years, the focus of its investment has shifted to the biotechnology and digital content industries; in line with Taiwan’s economic transformation and strategic development directions.
The Fund’s investment scope currently embraces semiconductors, optoelectronics, communications, financial services, precision machinery, transportation infrastructure, and biotechnology. The primary goal of the Fund is to serve as a catalyst for Taiwan’s economic development and to accomplish a multiplier effect in the courses of its investment process.
Economic development is the aspiration of all people in Taiwan. It is our expectation that the Development Fund can serve as a driver for Taiwan’s economy. Not only would the Fund propel forward our industries on the international stage, it would enable us to accomplish new grounds of industrial and economic achievements.
Chuan Lin, chairman of TTY Biopharm, one of Taiwan’s leading domestic biomedical players, highlights his ambition to lead the local success story onto the global stage. Chuan goes on to…
Grace Yeh, president and founder of PharmaEngine, gives an update on the company’s recent growth and development of their second nanomedicine cancer treatment. Yeh goes on to explain the unique…
Researchers from Taiwan and the USA may have found a vaccine for the Middle East respiratory syndrome coronavirus (MERS-CoV) – a deadly emerging disease with a mortality rate of over…
Deputy Minister for Science and Technology on Taiwan Fong Chin Su gives his insights on innovation, cybersecurity, and the current state of one of the world’s most exciting biotech industries.…
Gou Jen Wang, the co-founder of Vida BioTechnology, and Bing Chen Gu, General Manager elaborate on how Vida BioTechnology provides added value to its customers by focusing on simplified use,…
Weichyun Wong, president of SCI Pharmtech, discusses the API manufacturer’s transition from a Swiss-owned affiliate to a Taiwanese company. He also talks technology and regulatory challenges, as well as what…
Eugene Huang, chairman, and Hua-Lin Wu, consultant of Blue Blood Biotech Corp., provide insightful information on BB-101, a protein proven to be efficient for wound healing, while sharing their vision…
Michael H.J. Lai, Founder of Body Organ Biomedical Corporation, discusses Ologen’s success as the first ever eye tissue repair product and highlights the importance of global exposure for Taiwan-based companies.…
Ken-Shwo Dai, president and CEO of Visgeneer, explains his biotech’s expertise in medtech, skincare, gene therapy and diagnostics, as well as his plans to take the company public. Can you…
Jassy Wang, CEO of MegaPro Biomedical, a nanomedicine development company specializing in developing nanoparticles and nanomicelles, discusses the evolving nanomedicine market in Taiwan and reveals the company’s plans for future…
Daniel Huang, CEO of Genomics Bioscience, Taiwan’s largest commercial genome sequencing company, and Chairman of Pharmigene, a global leader in the development and manufacturing of genetic tests, documents how he…
Yvonne Huang, VP of Aquavan, a company developing the most sophisticated high-tech green biotechnology platform for the extraction of plants, discusses their innovative technology and business scope while contributing to…
See our Cookie Privacy Policy Here
